Ref. EJVES MAY 2016
This is the first systematic review of this kind. Very interesting findings.
Seven studies, comprising 461 patients were included in this systematic review. Overall weighted prevalence of coagulopathy was 12.3% (95% CI 10.7–13.9), 11.7% for INR (95% CI 1–31.6), 10.1% for platelet count (95% CI 1–26.8), and 11.1% for aPTT (95% CI 0.78–31). Fibrinogen serum concentration level was normal in 97%, and 46.2% (n = 55) of patients had elevated D-dimer. Only 6% of the entire population demonstrated significant coagulopathy. DIC was noted in 2.4% of the population.
So the question is: do you consider heparin for those patients?